Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals, to Add Nasal Swab Application of Anti-Nausea Product

IRVINE, Calif., Nov. 6, 2012 (GLOBE NEWSWIRE) -- Itonis, Inc. (OTC:ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam® Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce that Itonis Pharmaceuticals plans to offer nasal swabs as well as nasal spray to deliver its recently announced over-the-counter homeopathic nasal spray for the treatment of nausea.

The Company feels that consumer experience with the product will be enhanced by giving each consumer a choice of either a nasal spray or a nasal swab. Regardless of the mode of delivery, nasal application of the anti-nausea preparation is preferable over oral delivery, which is often difficult to tolerate for people experiencing nausea.

The nasal application of the anti-nausea preparation via spray or swab is expected to be more effective through the use of more tolerable ingredients. This anti-nausea offering has the advantage of avoiding oral ingestion while the consumer is suffering from symptoms of nausea. Plus, the preparation does not include zinc.

Dr. Hensley commented, "This is a win-win to offer consumers the option of a spray or swab to apply the anti-nausea preparation, and especially when they are suffering from nausea that would hinder any swallowing of medication."

About Itonis Pharmaceuticals

Itonis Pharmaceuticals, a new division of Itonis, Inc., is headed by Charles Hensley, Ph.D. This division's mission is to create and market over-the-counter and prescription homeopathic products that better people's lives. Dr. Hensley is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic preparations. He was a founder of Geltech, LLC, the company that launched the Zicam® Cold Remedy, making the product a household name and forever changing the marketing and product placement paradigm for homeopathic drugs in the United States. Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of several other common ailments and other chronic diseases.

About Itonis, Inc.

Itonis, Inc. was incorporated in the state of Nevada on July 5, 2005 under the name of Kenshou, Inc., which later changed to Itonis, Inc. on December 2, 2005. For more information please visit www.itonisholdings.com.

Safe Harbor:

Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.

CONTACT: Michael Biddick mike@itonisholdings.com 9495291588Source:Itonis Inc.